← Leaderboards

Kathryn L Schwertfeger

University Of Minnesota

Google Scholar ↗PubMed ↗ORCID ↗

$10,989,964

Attributed

$12,584,243

Total exposure

11

Grants

7

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2M · FY2005–25

$2.5M$1.9M$1.3M$625K$0

'05

'06

'07

'08

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$12,584,243 · 11

By mechanism

R01$10,758,065 · 6

R25$886,449 · 1

R21$719,951 · 2

F32$134,544 · 1

P30$85,234 · 1

Top collaborators

Most similar at University Of Minnesota

Same institution · by research overlap

Others in their field

Top investigators on “Macrophage”

Craig B Thompson · Sloan-Kettering Inst Can Research$41,669,179
Howard Eliot Gendelman · Children'S Memorial Hospital (Chicago)$41,668,744
Selwyn M Vickers · University Of Alabama At Birmingham$40,969,055
Alan A Aderem · University Of Washington$38,969,733
Alan Richard Tall · Columbia University Health Sciences$38,053,695
John S Condeelis · Yeshiva University$33,855,255

Research focus

MacrophageNeoplasm MetastasisResponsePhenotypeMouse ModelTumor ProgressionEnvironmentCytokineMalignant Breast NeoplasmMalignant NeoplasmsTumorPathway InteractionsMammary GlandAutomobile DrivingTissuesTumor MicroenvironmentMammary NeoplasmsIn VivoNeoplastic CellBaseSignal PathwayCellsTumorigenicNovel Therapeutic Intervention

Grant awards (42)

Regulation of tumor associated macrophage function by STAT5 in breast cancer$499,744

R01 · FY2025 · CA · contact PI

Functions of ductal- and stromal-associated macrophages in the mammary gland$484,361

R01 · FY2025 · HD

Defining the contributions of Lyve-1 expressing macrophages to breast cancer growth and progression$414,689

R01 · FY2025 · CA · contact PI

Contributions of FGFR-Mediated Tumor-Stromal Interactions to Breast Cancer Growth and Progression$378,466

R01 · FY2025 · CA · contact PI

Cancer Research Education And Training Experience$183,477

R25 · FY2025 · CA

Cellular Mechanisms$50,598

P30 · FY2025 · CA · contact PI

Functions of ductal- and stromal-associated macrophages in the mammary gland$479,517

R01 · FY2024 · HD

Defining the contributions of Lyve-1 expressing macrophages to breast cancer growth and progression$393,956

R01 · FY2024 · CA · contact PI

Contributions of FGFR-Mediated Tumor-Stromal Interactions to Breast Cancer Growth and Progression$359,542

R01 · FY2024 · CA · contact PI

Cancer Research Education And Training Experience$182,908

R25 · FY2024 · CA

Cellular Mechanisms$34,636

P30 · FY2024 · CA · contact PI

Functions of ductal- and stromal-associated macrophages in the mammary gland$484,361

R01 · FY2023 · HD

Defining the contributions of Lyve-1 expressing macrophages to breast cancer growth and progression$406,396

R01 · FY2023 · CA · contact PI

Contributions of FGFR-Mediated Tumor-Stromal Interactions to Breast Cancer Growth and Progression$370,897

R01 · FY2023 · CA · contact PI

Cancer Research Education And Training Experience$162,095

R25 · FY2023 · CA

Functions of ductal- and stromal-associated macrophages in the mammary gland$497,579

R01 · FY2022 · HD

Defining the contributions of Lyve-1 expressing macrophages to breast cancer growth and progression$414,689

R01 · FY2022 · CA · contact PI

Contributions of FGFR-Mediated Tumor-Stromal Interactions to Breast Cancer Growth and Progression$378,466

R01 · FY2022 · CA · contact PI

Regulation of tissue resident macrophages during mammary gland development$377,300

R01 · FY2022 · HD · contact PI

Cancer Research Education And Training Experience$173,242

R25 · FY2022 · CA

Regulation of tissue resident macrophages during mammary gland development$377,300

R01 · FY2021 · HD · contact PI

Contributions of FGFR-mediated tumor-stromal interactions to breast cancer growth and progression$352,275

R01 · FY2021 · CA · contact PI

Cancer Research Education And Training Experience$184,727

R25 · FY2021 · CA

Regulation of tissue resident macrophages during mammary gland development$385,000

R01 · FY2020 · HD · contact PI

Contributions of FGFR-mediated tumor-stromal interactions to breast cancer growth and progression$352,275

R01 · FY2020 · CA · contact PI

Dissecting the functions of diverse macrophage populations in the metastatic niche$161,398

R21 · FY2020 · CA

Regulation of tissue resident macrophages during mammary gland development$385,000

R01 · FY2019 · HD · contact PI

Contributions of FGFR-mediated tumor-stromal interactions to breast cancer growth and progression$341,706

R01 · FY2019 · CA · contact PI

Dissecting the functions of diverse macrophage populations in the metastatic niche$194,893

R21 · FY2019 · CA

Regulation of tissue resident macrophages during mammary gland development$385,000

R01 · FY2018 · HD · contact PI

Contributions of FGFR-mediated tumor-stromal interactions to breast cancer growth and progression$351,704

R01 · FY2018 · CA · contact PI

Contributions of FGFR-mediated tumor-stromal interactions to breast cancer growth and progression$349,416

R01 · FY2017 · CA · contact PI

Inflammation in Breast Cancer Initiation and Promotion$313,325

R01 · FY2015 · CA · contact PI

(PQB-3) Characterization of the immune response during mammary tumor initiation$198,360

R21 · FY2015 · CA · contact PI

Inflammation in Breast Cancer Initiation and Promotion$303,925

R01 · FY2014 · CA · contact PI

(PQB-3) Characterization of the immune response during mammary tumor initiation$165,300

R21 · FY2014 · CA · contact PI

Inflammation in Breast Cancer Initiation and Promotion$294,526

R01 · FY2013 · CA · contact PI

Inflammation in Breast Cancer Initiation and Promotion$313,325

R01 · FY2012 · CA · contact PI

Inflammation in Breast Cancer Initiation and Promotion$313,325

R01 · FY2011 · CA · contact PI

FGFR in Mammary Gland Development and Breast Cancer$48,928

F32 · FY2005 · CA

FGFR in Mammary Gland Development and Breast Cancer$47,296

F32 · FY2004 · CA

FGFR in Mammary Gland Development and Breast Cancer$38,320

F32 · FY2002 · CA